1. Home
  2. ONTO vs GKOS Comparison

ONTO vs GKOS Comparison

Compare ONTO & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONTO
  • GKOS
  • Stock Information
  • Founded
  • ONTO 1940
  • GKOS 1998
  • Country
  • ONTO United States
  • GKOS United States
  • Employees
  • ONTO N/A
  • GKOS N/A
  • Industry
  • ONTO Industrial Machinery/Components
  • GKOS Medical/Dental Instruments
  • Sector
  • ONTO Industrials
  • GKOS Health Care
  • Exchange
  • ONTO Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • ONTO 8.3B
  • GKOS 8.4B
  • IPO Year
  • ONTO N/A
  • GKOS 2015
  • Fundamental
  • Price
  • ONTO $159.55
  • GKOS $125.83
  • Analyst Decision
  • ONTO Strong Buy
  • GKOS Strong Buy
  • Analyst Count
  • ONTO 9
  • GKOS 13
  • Target Price
  • ONTO $246.88
  • GKOS $161.00
  • AVG Volume (30 Days)
  • ONTO 1.1M
  • GKOS 722.6K
  • Earning Date
  • ONTO 02-06-2025
  • GKOS 02-20-2025
  • Dividend Yield
  • ONTO N/A
  • GKOS N/A
  • EPS Growth
  • ONTO 65.04
  • GKOS N/A
  • EPS
  • ONTO 4.06
  • GKOS N/A
  • Revenue
  • ONTO $987,321,000.00
  • GKOS $383,481,000.00
  • Revenue This Year
  • ONTO $18.60
  • GKOS $22.69
  • Revenue Next Year
  • ONTO $15.63
  • GKOS $26.76
  • P/E Ratio
  • ONTO $39.28
  • GKOS N/A
  • Revenue Growth
  • ONTO 21.01
  • GKOS 21.85
  • 52 Week Low
  • ONTO $145.15
  • GKOS $83.90
  • 52 Week High
  • ONTO $238.93
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • ONTO 33.73
  • GKOS 29.90
  • Support Level
  • ONTO $168.43
  • GKOS $142.51
  • Resistance Level
  • ONTO $180.00
  • GKOS $161.78
  • Average True Range (ATR)
  • ONTO 7.97
  • GKOS 5.74
  • MACD
  • ONTO -3.94
  • GKOS -1.65
  • Stochastic Oscillator
  • ONTO 0.84
  • GKOS 2.39

About ONTO Onto Innovation Inc.

Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the largest sources of total revenue.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Share on Social Networks: